Ofmit Injection

About Ofmit 8 mg/4 ml Injection

Ofmit is an anti-emetic injection that helps stop nausea and vomiting by blocking a body signal that triggers the vomiting reflex. It is given by a healthcare professional, usually in a clinic or hospital setting.

There are 74 brands of Ondansetron listed in Bangladesh. 26 of them have a lower unit price than Ofmit. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.

What is Ofmit 8 mg/4 ml Injection?

Ofmit 8 mg/4 ml Injection contains ondansetron, an anti-emetic medicine. It belongs to a group that blocks serotonin signals in the gut and brain that set off the vomiting reflex. Doctors use it to help prevent and treat nausea and vomiting linked to cancer chemotherapy, radiotherapy, and after surgery. It comes as an injection in a 4 ml ampoule, supplied in a 10's pack, and is given by a healthcare professional. The doctor decides the dose and course for each person.

Uses of Ofmit

Ofmit Injection is used to help prevent and treat nausea and vomiting. Doctors may give it to people having cancer chemotherapy or radiotherapy, and to people recovering from surgery. It is an anti-emetic, meaning it works against vomiting rather than treating the underlying condition. The doctor decides whether it is suitable and how it fits into a person's overall treatment.

How to use Ofmit

Ofmit Injection is given by a doctor, nurse or other trained healthcare professional, usually in a clinic or hospital. It is not meant for self-injection at home. The doctor decides the dose, how it is given and how long the course lasts. Tell the healthcare team about any other medicines or health conditions before it is given.

Side effects of Ofmit

Common side effects include headache, constipation and diarrhoea, and most are mild or moderate. Some people have reported a feeling of flushing or warmth, hiccups, and changes in liver enzyme tests. Rash has been reported in some patients. Rarely, serious reactions such as allergic reactions, breathing difficulty, fast heartbeat and chest pain have been reported. Tell the doctor or nurse if you feel unwell after the injection.

Safety and precautions

Do not receive Ofmit Injection if you are allergic to ondansetron or any of its ingredients, or if you are taking apomorphine. Tell the doctor if you have had allergic reactions to similar anti-emetic medicines, or if you have had recent abdominal surgery, as the medicine may hide certain gut problems. It does not stimulate gut movement and is not a replacement for other treatments. Ask the doctor before use if you are pregnant, planning pregnancy or breastfeeding, because there is not enough evidence in pregnancy. The doctor decides if it is suitable for you.

Frequently asked questions

What does the generic name ondansetron mean?

Ondansetron is the generic name of the active ingredient in Ofmit Injection. It is a serotonin receptor blocker used to help prevent and treat nausea and vomiting. Generic names are standard names used for the medicine worldwide, whatever the brand.

What is Ofmit Injection used for and what kind of medicine is it?

Ofmit Injection is an anti-emetic medicine. Doctors use it to help prevent and treat nausea and vomiting linked to cancer chemotherapy, radiotherapy, and after surgery. It is given by a healthcare professional, and the doctor decides the dose and course.

Who should avoid Ofmit Injection or ask the doctor first?

People allergic to ondansetron or its ingredients should not receive it, and it should not be used with apomorphine. Ask the doctor first if you have had recent abdominal surgery, or if you are pregnant, planning pregnancy or breastfeeding. The doctor will decide if it is suitable for you.

What is the price of Ofmit Injection?

The listed price is ৳ 30.00.

Injection
Generic name
Ondansetron
Strength
8 mg/4 ml
Dosage form
Injection
Manufactured by
Nuvista Pharma Ltd
Price in Bangladesh

৳ 29.4 ৳ 30.00 2% off unit price

Price updated: 1 Jul 2022

Indications

Ondansetron is a serotonin subtype 3 (5-HT3) receptor antagonist indicated:
  • Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
  • Prevention and treatment of post-operative nausea and vomiting.
  • Prevention of radiotherapy-induced nausea and vomiting.

Pharmacology

Ondansetron is a potent, highly selective 5HT3 receptor-antagonist. Its precise mode of action in the control of nausea and vomiting is not known. Chemotherapeutic agents and radiotherapy may cause release of 5HT in the small intestine initiating a vomiting reflex by activating vagal afferents via 5HT3 receptors. Ondansetron blocks the initiation of this reflex. Activation of vagal afferents may also cause a release of 5HT in the area postrema, located on the floor of the fourth ventricle, and this may also promote emesis through a central mechanism. Thus, the effect of ondansetron in the management of the nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy is probably due to antagonism of 5HT3 receptors on neurons located both in the peripheral and central nervous system. The mechanisms of action in post-operative nausea and vomiting are not known but there may be common pathways with cytotoxic induced nausea and vomiting.

Dosage & Administration

Chemotherapy-Induced Nausea and Vomiting-
Adults, Pediatric patients (6 months to 18 years):
  • 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
  • 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
  • Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Radiotherapy-Induced Nausea and Vomiting-
Adults:
  • 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
  • 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
  • Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Postoperative Nausea and Vomiting-
Adults:
  • 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
  • 4 mg orodispersible tablet: 16 mg
  • Injection: 4 mg
Pediatrics (>40 kg): Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg

Chemotherapy-induced Nausea and Vomiting-
Adults/Geriatric/Child of 12 years or over:
  • Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
  • Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Pediatric (4-11 years): 5 ml (4 mg) Ondansetron Oral Solution should be taken 30 minutes before the start of chemotherapy. The other 2 doses should be taken 4 and 8 hours after the first dose. Then 5 ml oral solution should be administered 3 times a day (every 8 hours) for 1-2 days after completion of chemotherapy.


Oral solution:

Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):
  • The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
  • For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
  • For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
  • For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
Postoperative Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):
  • 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia


Oral Soluble Film:

Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:
  • Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
Prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy:
  • Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
  • Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
  • Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
  • Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.

Interaction

Ondansetron does not itself appear to induce or inhibit the cytochrome P-450 drug-metabolizing enzyme system of the liver. Because Ondansetron is metabolized by hepatic cytochrome P-450 drug-metabolizing enzymes, inducers or inhibitors of these enzymes may change the clearance and hence, the half-life of Ondansetron. On the basis of available data, no dosage adjustment of Ondasetron is recommended for patients on these drugs.

Contraindications

Contraindicated in patients known to have hypersensitivity to the drug or any of its components. Concomitant use of apomorphine.

Side Effects

Frequently reported adverse events were headache, constipation and diarrhea, but the majority have been mild or moderate in nature. In chemotherapy-induced nausea and vomiting, rash has occurred in approximately 1% of patients receiving Ondansetron. There also have been reports to a sensation of flushing or warmth, hiccups and liver enzyme abnormalities. Rare cases of anaphylaxis, brochospasm, tachycardia, angina (chest pain), hypokalemia, shortness of breath have also been reported, except for bronchospasm and anaphylaxis, the relationship to Ondansetron is unclear. There have been no evidence to extrapyramidal reactions, in rare case oculogyric crisis appearing alone, as well as with other dystonic reactions without definitive clinical evidence. In case of PONV, with the exception of headache, rates of these events were not significantly different in the Ondansetron and placebo groups.

Pregnancy & Lactation

Carcinogenic effects were not seen in 2-year studies in rats and mice with oral Ondansetron doses up to 10 and 30 mg/kg per day, respectively. Ondansetron was not mutagenic in standard tests for mutagenicity. Oral administration of Ondansetron up to 15 mg/kg per day did not affect fertility or general reproduction performance of male and female rats.

Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.

Precautions & Warnings

Hypersensitivity reactions have been reported in patients who have exhibited hypersensitivity to other selective 5-HT3 receptor antagonists. Ondansetron is not a drug that stimulates gastric or intestinal peristalsis. It should not be used instead of nasogastric suction. The use of Ondansetron in patients following abdominal surgery or in patients with chemotherapy-induced nausea and vomiting may mask a progressive ileus and/or gastric distension.

Storage Conditions

Store at temperature not exceeding 30ºC in a dry place. Protect from light and moisture.

Alternative brands of Ondansetron

Other brands with the same generic name, cheapest first.

Periset Suppository

16 mg

Ondansetron

The ACME Laboratories Ltd.

৳ 0.98 ৳ 1 2% off per unit

Oncodex Tablet

4 mg

Ondansetron

Jayson Pharmaceuticals Ltd.

৳ 4.44 ৳ 4.53 2% off per unit

Seton Tablet

4 mg

Ondansetron

Delta Pharma Limited

৳ 4.9 ৳ 5.00 2% off per unit

Seton Tablet

8 mg

Ondansetron

Delta Pharma Limited

৳ 4.9 ৳ 5.00 2% off per unit

Oncodex Tablet

8 mg

Ondansetron

Jayson Pharmaceuticals Ltd.

৳ 7.9 ৳ 8.06 2% off per unit

Emiteron Tablet

8 mg

Ondansetron

Premier Pharmaceuticals Ltd.

৳ 8.82 ৳ 9.00 2% off per unit

Periset Tablet

8 mg

Ondansetron

The ACME Laboratories Ltd.

৳ 9.83 ৳ 10.03 2% off per unit

Osetron Tablet

8 mg

Ondansetron

Advanced Chemical Industries PLC

৳ 9.87 ৳ 10.07 2% off per unit

See all 74 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.